Overview
Immunotherapy is a therapeutic strategy that harnesses or modifies the body's immune system to recognize and destroy diseased cells, most prominently malignant tumors. Rather than directly killing cancer cells like cytotoxic chemotherapy or radiation, it restores or amplifies immune surveillance that tumors evade. Major modalities include immune checkpoint inhibitors that block regulatory pathways such as programmed cell death protein-1 (PD-1) and its ligand to release suppressed T-cell activity; adoptive cell therapies including chimeric antigen receptor (CAR) T cells engineered to target tumor antigens; cytokine and interferon administration; therapeutic vaccines; and monoclonal antibodies directed at tumor-associated targets. In oncology, immunotherapy is applied across malignancies such as melanoma, where checkpoint blockade and combinations with radiation have reshaped treatment, and it is increasingly integrated with surgery and conventional regimens. Its effectiveness depends on accurate immunomonitoring, including immunoassays and immunogenomic profiling that characterize tumor antigens, immune cell populations, and response biomarkers. Emerging directions combine immunotherapy with nanotechnology for targeted delivery and explore oncofetal antigens and molecular diagnostics to refine patient selection. Challenges include immune-related adverse events, variable response rates, and mechanisms of resistance, all active areas of hematologic and oncologic research aimed at extending durable benefit to more patients.
Research published in this journal
10 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Immunotherapy Usage Has Not Increased Sub-Lobar Pulmonary Resections Despite Reduced Pneumonectomies
Avant Garde Alleviation -Cancer Immunotherapy
Nanotechnology Meets Immunotherapy: CAR-T Cells Technology and Beyond
The Current Immunoassays and Emerging Immunogenomic Approaches for Immunomonitoring Cancer and Infectious Diseases
Alpha-Fetoprotein and its Receptor: More Than Oncofoetal Antigens.
Anti-DPPX-Encephalitis in A Patient with Cerebral Vasculitis and Connective Tissue Disease
Molecular Diagnosis in Clinical Management and Diagnosis of Thyroid Cancer
Challenger and Propose Novel Methods and Techniques for Prevention, Prognosis, Diagnosis, Imaging, Screening, Treatment and Management of Lung Cancer
Blockade of Programmed Cell Death Protein-1 Pathway for the Treatment of Melanoma
How this research is being cited
The 10 articles above have been cited 42 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2024 · Experimental Dermatology
-
2024 · Experimental Dermatology
-
2024 · WIREs Mechanisms of Disease
-
2024 · Journal of Environmental Pathology, Toxicology and Oncology
-
2023 · Biosensors and Bioelectronics
-
2023 · International Immunopharmacology
-
2023 · WIREs Mechanisms of Disease
-
2023 · International Journal of Pharmaceutical Sciences Review and Research
A sample of recent works citing this journal's research on Immunotherapy, linking to each citing work.